Malin Ryner

556 total citations
11 papers, 247 citations indexed

About

Malin Ryner is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Malin Ryner has authored 11 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Malin Ryner's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Multiple Sclerosis Research Studies (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Malin Ryner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Multiple Sclerosis Research Studies (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Malin Ryner collaborates with scholars based in Sweden, Austria and Denmark. Malin Ryner's co-authors include Anna Fogdell‐Hahn, Jan Hillert, Nicky Dunn, Katharina Fink, Lars Alfredsson, Fredrik Piehl, Ali Manouchehrinia, Luca Piccoli, Tomas Olsson and AK Hedström and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Immunological Methods.

In The Last Decade

Malin Ryner

11 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malin Ryner Sweden 8 125 104 82 54 49 11 247
Ivana Kovářová Czechia 4 158 1.3× 61 0.6× 9 0.1× 80 1.5× 30 0.6× 12 249
Christian Roß Denmark 3 211 1.7× 88 0.8× 62 0.8× 88 1.6× 125 2.6× 6 348
LM Vilá Puerto Rico 10 54 0.4× 160 1.5× 66 0.8× 13 0.2× 267 5.4× 12 301
Kai Jensen Denmark 3 234 1.9× 87 0.8× 56 0.7× 93 1.7× 134 2.7× 5 313
Louis Christodoulou United Kingdom 4 35 0.3× 60 0.6× 71 0.9× 12 0.2× 13 0.3× 5 186
А. С. Авдеева Russia 9 29 0.2× 70 0.7× 31 0.4× 29 0.5× 186 3.8× 69 274
Melinda Kedves Hungary 5 36 0.3× 85 0.8× 18 0.2× 16 0.3× 172 3.5× 6 238
Chiharu Iwahashi Japan 9 32 0.3× 14 0.1× 65 0.8× 19 0.4× 33 0.7× 31 260
Ana M. Suelves United States 10 43 0.3× 18 0.2× 79 1.0× 7 0.1× 92 1.9× 21 400
O Nived Sweden 6 20 0.2× 78 0.8× 32 0.4× 17 0.3× 113 2.3× 6 167

Countries citing papers authored by Malin Ryner

Since Specialization
Citations

This map shows the geographic impact of Malin Ryner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Ryner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Ryner more than expected).

Fields of papers citing papers by Malin Ryner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malin Ryner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Ryner. The network helps show where Malin Ryner may publish in the future.

Co-authorship network of co-authors of Malin Ryner

This figure shows the co-authorship network connecting the top 25 collaborators of Malin Ryner. A scholar is included among the top collaborators of Malin Ryner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malin Ryner. Malin Ryner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schaik, Barbera D. C. van, Antoine H. C. van Kampen, Taco W. Kuijpers, et al.. (2022). Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis. Journal of Neuroimmunology. 370. 577932–577932. 2 indexed citations
2.
Faustini, Francesca, Nicky Dunn, Nastya Kharlamova, et al.. (2021). First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis. Arthritis Research & Therapy. 23(1). 211–211. 16 indexed citations
3.
Kharlamova, Nastya, Nicky Dunn, Malin Ryner, et al.. (2020). Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier. Frontiers in Immunology. 11. 1365–1365. 18 indexed citations
4.
Deisenhammer, Florian, Anders Sjödin, Malin Ryner, et al.. (2018). Prediction of natalizumab anti-drug antibodies persistency. Multiple Sclerosis Journal. 25(3). 392–398. 7 indexed citations
5.
Kramer, Daniel, Poul Erik Jensen, Malin Ryner, et al.. (2017). Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta. Frontiers in Neurology. 8. 305–305. 7 indexed citations
6.
Dunn, Nicky, Malin Ryner, Ali Manouchehrinia, et al.. (2017). Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies. Multiple Sclerosis Journal. 24(9). 1224–1233. 85 indexed citations
7.
Ryner, Malin, Poul Erik Jensen, Florian Deisenhammer, et al.. (2016). Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta. Journal of Immunological Methods. 430. 1–9. 7 indexed citations
8.
9.
Link, Jenny, Malin Ryner, Katharina Fink, et al.. (2014). Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis. PLoS ONE. 9(3). e90479–e90479. 25 indexed citations
10.
Hedström, Anna Karin, Malin Ryner, Anna Fogdell‐Hahn, et al.. (2013). Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a. Multiple Sclerosis Journal. 20(4). 445–450. 36 indexed citations
11.
Hedström, AK, Lars Alfredsson, Malin Ryner, et al.. (2013). Smokers run increased risk of developing anti-natalizumab antibodies. Multiple Sclerosis Journal. 20(8). 1081–1085. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Kovářová Breakdown of academic impact, for papers by Christian Roß Breakdown of academic impact, for papers by LM Vilá Breakdown of academic impact, for papers by Kai Jensen Breakdown of academic impact, for papers by Louis Christodoulou Breakdown of academic impact, for papers by А. С. Авдеева Breakdown of academic impact, for papers by Melinda Kedves Breakdown of academic impact, for papers by Chiharu Iwahashi Breakdown of academic impact, for papers by Ana M. Suelves Breakdown of academic impact, for papers by O Nived
Rankless by CCL
2026